Pharma-Bio Serv, Inc. PBSV
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.34M | 2.70M | 2.30M | 2.15M | 1.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.34M | 2.70M | 2.30M | 2.15M | 1.96M |
| Cost of Revenue | 1.64M | 1.80M | 1.57M | 1.40M | 1.39M |
| Gross Profit | 691.70K | 902.00K | 722.40K | 748.90K | 574.30K |
| SG&A Expenses | 763.50K | 757.40K | 816.90K | 882.20K | 888.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.41M | 2.56M | 2.39M | 2.28M | 2.28M |
| Operating Income | -71.80K | 144.70K | -94.50K | -133.30K | -313.90K |
| Income Before Tax | -11.10K | 239.40K | 36.50K | 4.30K | -209.00K |
| Income Tax Expenses | 3.10K | 6.40K | 3.60K | 4.40K | -4.80K |
| Earnings from Continuing Operations | -14.20K | 233.00K | 32.90K | -100.00 | -204.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.20K | 233.00K | 32.90K | -100.00 | -204.30K |
| EBIT | -71.80K | 144.70K | -94.50K | -133.30K | -313.90K |
| EBITDA | -58.10K | 158.30K | -79.70K | -117.50K | -298.10K |
| EPS Basic | 0.00 | 0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.01 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.01 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.01 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 22.90M | 22.90M | 22.91M | 22.95M | 22.93M |
| Average Diluted Shares Outstanding | 22.91M | 22.91M | 22.91M | 22.95M | 22.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 737.22% | -- | 0.00% | -- |